Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2021 Sep 1;40:277. doi: 10.1186/s13046-021-02079-2

Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways

Run-Wei Yang 1,2,3,#, Ying-Yue Zeng 1,2,3,#, Wen-Ting Wei 1,2,3,#, Yan-Mei Cui 1,2,3, Hui-Ying Sun 1,2,3, Yue-Long Cai 1,2,3, Xin-Xin Nian 1,2,3, Yun-Teng Hu 1,2,3, Yu-Ping Quan 1,2,3, Sheng-Lu Jiang 1,2,3, Meng Wang 1,2,3, Ya-Li Zhao 1,2,3, Jun-Feng Qiu 1,2,3, Ming-Xuan Li 1,2,3, Jia-Huan Zhang 1,2,3, Mei-Rong He 4, Li Liang 1,2,3, Yan-Qing Ding 1,2,3,5,, Wen-Ting Liao 1,2,3,5,
PMCID: PMC8408939  PMID: 34470659

Retraction Note: J Exp Clin Cancer Res 35, 152 (2016)

https://doi.org/10.1186/s13046-016-0426-8

The Editor-in-Chief has retracted this article at the request of Wen-Ting Liao. The author stated that the data presented in Fig. 2F (HE and Ki67) were published in the authors’ previous study [1], and the data in Figs. 1C (α-tubulin, FOXO3, p-AKT) and 2A (α-tubulin) were published in [2]. In addition, the same α-tubulin western blot bands are presented in Figs. 2A and 3A. Thus, the corresponding author stated that the authors have no confidence in the reliability of the data and conclusions reported in this article. Run-Wei Yang, Ying-Yue Zeng, Wen-Ting Wei, Yan-Mei Cui, Hui-Ying Sun, Li Liang, and Wen-Ting Liao agree to this retraction. Yue-Long Cai, Xin-Xin Nian, Yun-Teng Hu, Yu-Ping Quan, Sheng-Lu Jiang, Meng Wang, Ya-Li Zhao, Jun-Feng Qiu, Ming-Xuan Li, Jia-Huan Zhang, Mei-Rong He, and Yan-Qing Ding have not responded to any correspondence about this retraction.

Footnotes

Run-Wei Yang, Ying-Yue Zeng and Wen-Ting Wei contributed equally to this work.

Contributor Information

Yan-Qing Ding, Email: dyq@fimmu.com.

Wen-Ting Liao, Email: liaowt2002@gmail.com.

References

  • 1.Cui Y-M, Jiang D, Zhang S-H, Wu P, Ye YP, Chen CM, Tang N, Liang L, Li TT, Qi L, Wang SY, Jiao HL, Lin J, Ding YQ, Liao WT. FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways. Cancer Lett. 2014;353(1):87–94. doi: 10.1016/j.canlet.2014.07.008. [DOI] [PubMed] [Google Scholar]
  • 2.Cui YM, Jiao HL, Ye YP, Chen CM, Wang JX, Tang N, Li TT, Lin J, Qi L, Wu P, Wang SY, He MR, Liang L, Bian XW, Liao WT, Ding YQ. FOXC2 promotes colorectal cancer metastasis by directly targeting MET. Oncogene. 2015;34(33):4379–4390. doi: 10.1038/onc.2014.368. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES